Metraipolis › archive › dc_9952a227fca7

Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management — Europe PMC PMID:40940824

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40940824
DOI
10.3390/cancers17172726
License (as archived)
solo-consultazione
Archived
2026-11-10T10:49:31.642Z
SHA-256 of the archived text
c5d7893d98a11aff7cbe6d4cc9c8bb203db1f346c8e60e05fa41fe8b1266ec7e
Stable URL of this page
https://metraipolis.com/documento/dc_9952a227fca7

How to cite

Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management — Europe PMC PMID:40940824 — Europe PMC (en), https://europepmc.org/article/MED/40940824 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9952a227fca7 (Metraipolis archive dc_9952a227fca7, sha256 c5d7893d98a11aff7cbe6d4cc9c8bb203db1f346c8e60e05fa41fe8b1266ec7e)
BibTeX
@misc{dc9952a227fca7,
  title = {Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management — Europe PMC PMID:40940824},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40940824},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9952a227fca7; sha256 c5d7893d98a11aff7cbe6d4cc9c8bb203db1f346c8e60e05fa41fe8b1266ec7e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40940824. Agents can read the archived copy with the MCP tool read_document.